The LILR family: modulators of innate and adaptive immune pathways in health and disease.

Leukocyte immunoglobulin (Ig)-like receptors [LILRs, also known as Ig-like transcripts (ILTs)] are a family of inhibitory and stimulatory receptors encoded within the leukocyte receptor complex and are expressed by immune cell types of both myeloid and lymphoid lineage. Several members of the LILR family recognize major histocompatibility complex class I. The immunomodulatory role of LILR receptors indicates that they may exert an influence on signaling pathways of both innate and adaptive immune systems. LILR activity can also influence the antigen-presenting properties of macrophages and dendritic cells and may thus play a role in T-cell tolerance. The wide-ranging effects of LILR signaling on immune cell activity imply that these receptors are likely to play an important role in a range of clinical situations including pregnancy, transplantation, and arthritis (including the human leukocyte antigen B27-associated spondyloarthropathies). In this review, we summarize current knowledge on the nature and function of LILRs, focusing on their regulation of immune cell activity and their potential role in disease.

[1]  D. Curtis,et al.  Analysis of candidate genes on chromosome 19 in coeliac disease: an association study of the KIR and LILR gene clusters. , 2002, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[2]  B. Drénou,et al.  HLA-G protein expression is not induced during malignant transformation. , 1999, Tissue antigens.

[3]  D. Cosman,et al.  The co-expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium. , 2002, The American journal of pathology.

[4]  J. S. Hunt,et al.  Decidual macrophages are potentially susceptible to inhibition by class Ia and class Ib HLA molecules. , 2002, Journal of reproductive immunology.

[5]  C. Ober,et al.  HLA-G in reproduction: studies on the maternal-fetal interface. , 2000, Human immunology.

[6]  Kouhei Tsumoto,et al.  Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Parham,et al.  Comparison of Chimpanzee and Human Leukocyte Ig-Like Receptor Genes Reveals Framework and Rapidly Evolving Genes1 , 2001, The Journal of Immunology.

[8]  Manfred Brockhaus,et al.  A Novel Inhibitory Receptor (ILT3) Expressed on Monocytes, Macrophages, and Dendritic Cells Involved in Antigen Processing , 1997, The Journal of experimental medicine.

[9]  R. Dummer,et al.  Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas. , 2001, The American journal of pathology.

[10]  P. Anton van der Merwe,et al.  The nature of molecular recognition by T cells , 2003, Nature Immunology.

[11]  M. Kubin,et al.  A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. , 1997, Journal of Immunology.

[12]  M. Colonna,et al.  Ig-Like Transcript 2 (ILT2)/Leukocyte Ig-Like Receptor 1 (LIR1) Inhibits TCR Signaling and Actin Cytoskeleton Reorganization1 , 2001, The Journal of Immunology.

[13]  L. Moretta,et al.  The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones. , 1999, International immunology.

[14]  G. Sármay,et al.  Immunoreceptor tyrosine-based inhibition motif-bearing receptors regulate the immunoreceptor tyrosine-based activation motif-induced activation of immune competent cells. , 1999, Immunology letters.

[15]  Eric O Long,et al.  A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors , 1997, Current Biology.

[16]  Eric O Long,et al.  A Human Histocompatibility Leukocyte Antigen (HLA)-G–specific Receptor Expressed on All Natural Killer Cells , 1999, The Journal of experimental medicine.

[17]  M. Kubin,et al.  A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. , 1997, Immunity.

[18]  J. Bell,et al.  Structure and function of the human MHC class Ib molecules HLA‐E, HLA‐F and HLA‐G , 1998, Immunological reviews.

[19]  G. Vlad,et al.  Interleukin-10 induces the upregulation of the inhibitory receptor ILT4 in monocytes from HIV positive individuals. , 2003, Human immunology.

[20]  P. Bjorkman,et al.  The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. , 1999, Immunity.

[21]  J. Kinet,et al.  Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1 , 1999, Oncogene.

[22]  P. Forte,et al.  Porcine aortic endothelial cells transfected with HLA-G are partially protected from xenogeneic human NK cytotoxicity. , 2000, Human immunology.

[23]  B. Baibakov,et al.  HLA‐G inhibits the functions of murine dendritic cells via the PIR‐B immune inhibitory receptor , 2002, European journal of immunology.

[24]  G. Ogg,et al.  Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. , 1998, Journal of immunology.

[25]  S. Bruno,et al.  Dual Effect of CD85/Leukocyte Ig-Like Receptor-1/Ig-Like Transcript 2 and CD152 (CTLA-4) on Cytokine Production by Antigen-Stimulated Human T Cells1 , 2002, The Journal of Immunology.

[26]  D. Jarrossay,et al.  Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon , 1999, Nature Medicine.

[27]  A. Nakamura,et al.  Impaired dendritic cell maturation and increased TH2 responses in PIR-B−/− mice , 2002, Nature Immunology.

[28]  C. Maliszewski,et al.  The MHC class I binding proteins LIR‐1 and LIR‐2 inhibit Fc receptor‐mediated signaling in monocytes , 1998, European journal of immunology.

[29]  V. Guiard,et al.  IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. , 1999, International immunology.

[30]  S. Olofsson,et al.  LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients , 2003, The Lancet.

[31]  L. Adorini,et al.  Cutting Edge: Differential Chemokine Production by Myeloid and Plasmacytoid Dendritic Cells1 , 2002, The Journal of Immunology.

[32]  M. Colonna,et al.  ILT receptors at the interface between lymphoid and myeloid cells. , 2000, Current topics in microbiology and immunology.

[33]  A. McMichael,et al.  Tetrameric Complexes of Human Histocompatibility Leukocyte Antigen (HLA)-G Bind to Peripheral Blood Myelomonocytic Cells , 1999, The Journal of experimental medicine.

[34]  M. Cooper,et al.  Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B. , 2001, The Journal of clinical investigation.

[35]  G. Stussi,et al.  HLA-G Inhibits Rolling Adhesion of Activated Human NK Cells on Porcine Endothelial Cells1 , 2001, The Journal of Immunology.

[36]  P. Parham,et al.  Differential Expression of Leukocyte Receptor Complex-Encoded Ig-Like Receptors Correlates with the Transition from Effector to Memory CTL1 , 2001, The Journal of Immunology.

[37]  Michael J. Wilson,et al.  Cutting Edge: Leukocyte Receptor Complex-Encoded Immunomodulatory Receptors Show Differing Specificity for Alternative HLA-B27 Structures1 , 2001, The Journal of Immunology.

[38]  M. Colonna,et al.  The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA‐G1 and HLA‐E molecules co‐expressed on target cells , 1999, European journal of immunology.

[39]  M. Colonna,et al.  Cutting Edge: Human Myeloid Cells Express an Activating ILT Receptor (ILT1) That Associates with Fc Receptor γ-Chain , 1999, The Journal of Immunology.

[40]  A. West,et al.  Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). , 2000, Immunity.

[41]  P. Parham,et al.  Conserved organization of the ILT/LIR gene family within the polymorphic human leukocyte receptor complex , 2001, Immunogenetics.

[42]  J. Bowen,et al.  Surface expression of HLA-C antigen by human extravillous trophoblast. , 2000, Placenta.

[43]  M. Colonna,et al.  Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways , 1997, European journal of immunology.

[44]  B. Seliger,et al.  Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma. , 2003, Cancer research.

[45]  M. Kubin,et al.  LIR9, an immunoglobulin-superfamily-activating receptor, is expressed as a transmembrane and as a secreted molecule. , 2003, Blood.

[46]  M. Feldmann,et al.  Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? , 2001, Annual review of immunology.

[47]  M. Llano,et al.  Human cytomegalovirus and natural killer‐mediated surveillance of HLA class I expression: a paradigm of host–pathogen adaptation , 2001, Immunological reviews.

[48]  D. Geraghty,et al.  Protein Expression and Peptide Binding Suggest Unique and Interacting Functional Roles for HLA-E, F, and G in Maternal-Placental Immune Recognition 1 , 2003, The Journal of Immunology.

[49]  A. McMichael,et al.  Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. , 2002, Arthritis and rheumatism.

[50]  M. Zenke,et al.  Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation. , 2004, Gene.

[51]  S. Beck,et al.  Plasticity in the organization and sequences of human KIR/ILT gene families. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[52]  G. Anastasi,et al.  The CD85/LIR-1/ILT2 Inhibitory Receptor Is Expressed by All Human T Lymphocytes and Down-Regulates Their Functions1 , 2000, The Journal of Immunology.

[53]  D. Cosman,et al.  Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[54]  A. McMichael,et al.  The role of HLA-B27 in spondyloarthritis , 1999, Immunogenetics.

[55]  J. Dausset,et al.  Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. , 1999, Cancer research.

[56]  Michael J. Wilson,et al.  Arrangement of the ILT gene cluster: a common null allele of the ILT6 gene results from a 6.7‐kbp deletion , 2000, European journal of immunology.

[57]  P. Bjorkman,et al.  Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor , 2003, Nature Immunology.

[58]  N. Rouas-Freiss,et al.  HLA-G in cancer: a way to turn off the immune system. , 2003, Seminars in cancer biology.

[59]  M. Colonna,et al.  Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4 , 2002, Nature Immunology.

[60]  K. Kärre.  NK Cells, MHC Class I Molecules and the Missing Self , 2002, Scandinavian journal of immunology.

[61]  R. Biassoni,et al.  Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Colonna,et al.  A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells , 1997, The Journal of experimental medicine.

[63]  G. Aversa,et al.  Interleukin 10 regulates cell surface and soluble LIR‐2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro , 2004, European journal of immunology.

[64]  A. West,et al.  Crystal structure of LIR-2 (ILT4) at 1.8 Å: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18 , 2002, BMC Structural Biology.

[65]  A. Nel,et al.  T-cell activation through the antigen receptor. Part 2: role of signaling cascades in T-cell differentiation, anergy, immune senescence, and development of immunotherapy. , 2002, The Journal of allergy and clinical immunology.

[66]  R. Dummer,et al.  HLA‐G and its KIR ligands in cancer – another enigma yet to be solved? , 2002, The Journal of pathology.

[67]  Masahiro Yamamura,et al.  Use of Genetic Profiling in Leprosy to Discriminate Clinical Forms of the Disease , 2003, Science.

[68]  J. Dausset,et al.  Specific activation of the non‐classical class I histocompatibility HLA‐G antigen and expression of the ILT2 inhibitory receptor in human breast cancer , 2002, The Journal of pathology.

[69]  R. Fauchet,et al.  Lung macrophages and dendritic cells express HLA-G molecules in pulmonary diseases. , 2002, Human immunology.

[70]  J. Bell,et al.  Functional characterization of HLA‐F and binding of HLA‐F tetramers to ILT2 and ILT4 receptors , 2000, European journal of immunology.

[71]  Kenneth G. C. Smith,et al.  Interleukin 4 Reduces Expression of Inhibitory Receptors on B Cells and Abolishes CD22 and FcγRII-mediated B Cell Suppression , 2002, The Journal of experimental medicine.